Celebrate BirdoTech's Grand Launch of Advanced CDMO Base & cGMP Plant in Chongqing

Join us in celebrating a momentous occasion as BirdoTech inaugurates its state-of-the-art CDMO base in Chongqing, China. This marks a significant milestone as we unveil our first c-GMP plant, a testament to our commitment to excellence in pharmaceutical manufacturing.

Spanning an impressive 67,000㎡, our new facility is a beacon of innovation, featuring three production workshops and a dedicated hydrogenation workshop. The facility is set to revolutionize our production capabilities, boasting a capacity of 100T once fully operational. 

The plant embodies our forward-thinking approach with its multifunctional workshop design. By integrating various functional unit reactions, we are poised to meet the diverse order demands of our clients with agility and precision. Moreover, we are excited to announce ongoing projects for the establishment of verification centers for oncology and hematology innovative drugs, further expanding our research and development prowess. As stated by Mr. Wang Lei, Chairman & CEO of BirdoTech, "The gradual commissioning of the facility will enable us to provide superior services to our clients through the integrated linkage of front and back ends, propelling the company into a new phase of development."

Birdo's new production plant is equipped with comprehensive production and related infrastructure, including solvent tank farm, high-pressure hydrogenation unit, waste treatment facilities, utility services, multi-function pilot plants, warehouses, QC/QA labs, and regulatory documentation offices. As practitioners of green chemistry and providers of long-term, stable supply services, we adhere strictly to RFT and OTIF standards, ensuring product quality and timely delivery. Guided by the QBD concept, the faility is also capable of conducting research and development and production of APIs that meet regulatory requirements in China, Japan, North America, Europe, and other regions. We provide research support and documentation that meet ICH risk management and GMP regulatory requirements.

  

 

As we embark on this new journey, we invite you to join us in shaping the future of the pharmaceutical industry. Together, we can achieve greater heights and contribute to the well-being of communities worldwide. Welcome to the new era of BirdoTech. 🚀